혈전 관리 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Clot Management Devices Market size is expected to reach USD 2.73 Billion in 2034 from USD 1.71 Billion (2025) growing at a CAGR of 5.34% during 2026-2034.

The Global Clot Management Devices Market is witnessing strong growth due to the increasing prevalence of cardiovascular diseases and thrombotic disorders. Blood clots can lead to serious medical conditions such as stroke, pulmonary embolism, and deep vein thrombosis, making effective clot removal and management essential in emergency medical care. Clot management devices are widely used in interventional procedures to remove or dissolve clots and restore normal blood flow.

Technological innovations have significantly improved the performance and safety of clot management devices. Mechanical thrombectomy systems, aspiration catheters, and clot retrieval devices are enabling physicians to treat clot-related conditions with greater precision and speed. The increasing adoption of minimally invasive treatment techniques is further supporting the growth of this market.

Looking ahead, the Global Clot Management Devices Market is expected to expand as healthcare providers continue to focus on advanced cardiovascular treatment solutions. Manufacturers are developing next-generation devices that improve clot removal efficiency while reducing procedural risks. With the rising incidence of stroke and other clot-related conditions, the demand for effective clot management technologies is projected to grow significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter-Directed Thrombolysis (CDT) devices
• Inferior vena cava filters (IVCF)

By Percutaneous Thrombectomy Devices Type

• Aspiration Thrombectomy Devices
• Percutaneous Mechanical Thrombectomy Devices

By End-use

• Diagnostic centers
• Hospitals

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Inc, Edwards Lifesciences Corporation, LeMaitre Vascular Inc, Vascular Solutions Inc, Straub Medical AG, Cook Medical, DePuy Synthes
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Neurovascular Embolectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Embolectomy Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Percutaneous Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Catheter-Directed Thrombolysis (CDT) devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Inferior vena cava filters (IVCF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PERCUTANEOUS THROMBECTOMY DEVICES TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Percutaneous Thrombectomy Devices Type
• 5.2. Aspiration Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Percutaneous Mechanical Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Percutaneous Thrombectomy Devices Type
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Percutaneous Thrombectomy Devices Type
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Percutaneous Thrombectomy Devices Type
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Percutaneous Thrombectomy Devices Type
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Percutaneous Thrombectomy Devices Type
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLOT MANAGEMENT DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 IVascular SLU
  • 9.2.4 Teleflex Inc
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 LeMaitre Vascular Inc
  • 9.2.7 Vascular Solutions Inc
  • 9.2.8 Straub Medical AG
  • 9.2.9 Cook Medical
  • 9.2.10 DePuy Synthes